Snowden Capital Advisors LLC Astrazeneca PLC Transaction History
Snowden Capital Advisors LLC
- $3.5 Billion
- Q3 2025
A detailed history of Snowden Capital Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Snowden Capital Advisors LLC holds 36,574 shares of AZN stock, worth $3.27 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
36,574
Previous 36,740
0.45%
Holding current value
$3.27 Million
Previous $2.57 Million
9.27%
% of portfolio
0.08%
Previous 0.08%
Shares
41 transactions
Others Institutions Holding AZN
# of Institutions
1,521Shares Held
502MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...